The cardiac diagnostic work-up in stroke patients-A subanalysis of the Find-AFRANDOMISED trial

Katrin Wasser1, Mark Weber-Krüger2, Falko Jürries2

  • 1Clinic for Neurology, University of Göttingen, Göttingen, Germany.

Plos One
|May 10, 2019
PubMed

Insights

Enhanced Holter-ECG monitoring significantly impacts therapeutic decisions in stroke patients by detecting atrial fibrillation. Echocardiography identifies high-risk patients but rarely changes therapy, suggesting a need for further investigation.

Area of Science:

  • Cardiology
  • Neurology
  • Medical Diagnostics

Background:

  • The optimal cardiac diagnostic workup for stroke patients remains debated, particularly the roles of echocardiography and prolonged Holter-ECG monitoring.
  • Evaluating the impact of detected pathologies on treatment and prognosis is crucial for acute ischemic stroke management.

Purpose of the Study:

  • To analyze the impact of echocardiography and Holter-ECG monitoring findings on therapeutic decisions and patient prognosis in acute ischemic stroke.
  • To compare the effectiveness of enhanced, prolonged Holter-ECG monitoring versus routine care in guiding treatment.

Main Methods:

  • A prospective, multicenter study (Find-AFRANDOMISED) randomized 398 ischemic stroke patients (≥60 years) to enhanced Holter-ECG or usual care.
  • Substudy compared therapeutic changes from echocardiography (TTE, TEE) and Holter-ECG (routine vs. enhanced/prolonged) and assessed patient prognosis.

Main Results:

  • Enhanced Holter-ECG monitoring detected atrial fibrillation (AF) in 27/200 patients, leading to therapy changes (NNCD 8). Routine ECG found AF in 12/198 (NNCD 17).
  • Transesophageal echocardiography (TEE) pathologies changed therapy in 14/89 cases (NNCD 12), while transthoracic echocardiography (TTE) changed therapy in 1/90 cases (NNCD 330).
  • Therapeutic decisions were most frequently altered by enhanced and prolonged Holter-ECG monitoring.

Conclusions:

  • Enhanced and prolonged Holter-ECG monitoring should be prioritized in future stroke guidelines due to its significant impact on therapeutic decisions.
  • Echocardiography identifies high-risk cardiovascular patients but infrequently leads to treatment changes, warranting further investigation by neurocardiologic teams.
Abstract

Related Concept Videos

Cardiac Output II: Effect of Stroke Volume on Cardiac Output01:22

Cardiac Output II: Effect of Stroke Volume on Cardiac Output

Cardiac output (CO), the amount of blood the heart pumps per minute, is a parameter in cardiovascular physiology determined by stroke volume and heart rate. Stroke volume, the amount of blood pushed from one of the ventricles per heartbeat, is influenced by preload, afterload, and contractility.
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
3.2K
Cardiac Output and Stroke Volume01:11

Cardiac Output and Stroke Volume

Cardiac output (CO) is an integral aspect of human physiology, reflecting the heart's efficiency and responsiveness to the body's needs. It represents the volume of blood that the left or right ventricle ejects into the aorta or pulmonary trunk each minute. The CO is calculated by multiplying the heart rate (HR)—the number of heartbeats per minute—by the stroke volume (SV)—the amount of blood pumped out with each heartbeat.
In an average resting adult male, the typical cardiac...
4.6K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.2K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
403
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
4.8K